You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematopoietic Stem Cell Mobilization

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • Idiopathic CD4-Positive
  • T-Lymphocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Non-interventional, Long-term Safety Data Collection of Zarzio®

Active, not recruiting
  • Hematopoietic Stem Cell Mobilization
    • Frankfurt/Main, Hessen, Germany
    • +1 more
    Jan 24, 2022

    Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

    Not yet recruiting
    • Granulocyte Colony-Stimulating Factor
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 31, 2023

    Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

    Completed
    Has Results
    • Multiple Myeloma
    • Stanford, California
      Stanford University
    Aug 17, 2022

    Hematologic Malignancies Trial in Lebanon (Cyclophosphamide)

    Completed
    Has Results
    • Hematologic Malignancies
    • Lebanon, New Hampshire
      Dartmouth Hitchcock Medical Center
    Jan 28, 2021

    Sickle Cell Disease Trial in Duarte (Plerixafor)

    Recruiting
    • Sickle Cell Disease
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Sickle Cell Disease Trial in Boston, Memphis (MGTA-145, Plerixafor)

    Recruiting
    • Sickle Cell Disease
    • Bethesda, Maryland
    • +2 more
    Nov 4, 2022

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

    Active, not recruiting
    Has Results
    • Acute Myelogenous Leukemia
    • +10 more
    • Atlanta, Georgia
    • +2 more
    Feb 9, 2022

    Multiple Myeloma, Non-hodgkin's Lymphoma, Hodgkin's Disease Trial in Stony Brook (TG-0054)

    Completed
    Has Results
    • Multiple Myeloma
    • +2 more
    • Stony Brook, New York
      Stony Brook University Hospital
    Apr 14, 2021

    Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

    Not yet recruiting
    • Lymphoma
    • Peripheral Blood Stem Cell Transplantation
    • Eltrombopag olamine
    • (no location specified)
    Jul 25, 2023

    Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Taiwan (TG-0054 (2.24 mg/kg), TG-0054 (3.14 mg/kg))

    Completed
    Has Results
    • Multiple Myeloma
    • +2 more
    • TG-0054 (2.24 mg/kg)
    • TG-0054 (3.14 mg/kg)
    • Chiayi, Taiwan
    • +5 more
    Apr 14, 2021

    Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

    Not yet recruiting
    • Granulocyte Colony-stimulating Factor
    • Stem Cell Mobilization
    • (no location specified)
    Jun 13, 2022

    Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Stony Brook, Nashville (TG-0054 combined with G-CSF)

    Completed
    Has Results
    • Multiple Myeloma
    • +2 more
    • TG-0054 combined with G-CSF
    • Stony Brook, New York
    • +1 more
    Apr 14, 2021

    Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

    Recruiting
    • Lymphoma
    • Multiple Myeloma
    • Hangzhou, Zhejiang, China
    • +6 more
    Sep 7, 2022

    Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

    Terminated
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +7 more
    Apr 13, 2022

    Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

    Not yet recruiting
    • Sickle Cell Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 8, 2022

    Beta-Thalassemia Trial (CS-101 injection)

    Not yet recruiting
    • Beta-Thalassemia
    • CS-101 injection
    • (no location specified)
    Sep 27, 2023

    Peripheral Blood Stem Cell Transplantation Trial in Sapporo (Pegfilgrastim)

    Completed
    • Peripheral Blood Stem Cell Transplantation
    • Sapporo, Hokkaido, Japan
      Hokkaido University Hospital
    Jan 20, 2021

    Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)

    Active, not recruiting
    • Multiple Myeloma
    • BL-8040 1.25mg/kg + G-CSF
    • Placebo +G-CSF
    • Los Angeles, California
    • +17 more
    Jun 14, 2022

    Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

    Recruiting
    • Haploidentical Hematopoietic Stem Cell Transplantation
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Sep 11, 2023

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))

    Completed
    Has Results
    • Healthy
    • AMD 3100 (Mozobil plerixafor)
    • Granulocyte colony-stimulating factor (G-CSF)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 21, 2021

    Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

    Recruiting
    • Chronic Granulomatous Disease X-linked (X-CGD)
    • Rome, Lazio, Italy
    • +1 more
    Oct 27, 2022